Evidence map›Paper›PMID 24139641›Full record

ReviewTrends in neurosciences2013

Modulation of neuronal activity by phosphorylation of the K-Cl cotransporter KCC2.

Kristopher T Kahle, Tarek Z Deeb, Martin Puskarjov, Liliya Silayeva, Bo Liang, Kai Kaila, Stephen J Moss

Abstract readReview
In one paragraph

Review in Trends in neurosciences, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 131 papers.

0numbers the graph read from it
0cells of the map it votes in
131citing papers in PubMed
8.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

131 citing papers in PubMed, 215 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. GABACellular and molecular neurobiology · 2026
    Review
  8. Article
  9. Article
  10. Direct energy consumption by inhibitory GABAFrontiers in neuroscience · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

71 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Kristopher T Kahle *Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Tarek Z Deeb *Department of Neuroscience, Tufts University School of Medicine, Boston, MA 02111, USA.
Martin Puskarjov *Department of Biosciences and Neuroscience Center, University of Helsinki, FI-00014 Helsinki, Finland.
Liliya SilayevaDepartment of Neuroscience, Tufts University School of Medicine, Boston, MA 02111, USA.
Bo LiangDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.
Kai KailaDepartment of Biosciences and Neuroscience Center, University of Helsinki, FI-00014 Helsinki, Finland.
Stephen J MossDepartment of Neuroscience, Tufts University School of Medicine, Boston, MA 02111, USA.
Harvard University · USTufts University · USUniversity of Helsinki · FIUniversity College London · GB

Funding

The Synthesis of GABA in Epileptic BrainP01NS054900 · NINDS · CHILDREN'S HOSP OF PHILADELPHIA · PI COULTER, DOUGLAS A · 2007 to 2011
$6.4M
Constructing inhibitory synapsesR01NS051195 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI MOSS, STEPHEN J · 2006 to 2014
$3.2M
Modulation of GABAB receptor signalingR01NS048045 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI MOSS, STEPHEN J · 2005 to 2010
$2.7M
The Regulation of GABAA Receptor Cell Surface StabilityR01NS047478 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI MOSS, STEPHEN J · 2005 to 2009
$2.1M
Novel actions of neurosteroids on GABA (A) receptor traffickingR01MH097446 · NIMH · TUFTS UNIVERSITY BOSTON · PI DAVIES, PAUL ANDREW, MOSS, STEPHEN J · 2013 to 2017
$2.1M
The role of ubiquitination in regulating GABA(A) receptor functional expressionR01NS056359 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI MOSS, STEPHEN J · 2007 to 2010
$1.4M
Impaired KCC2 function underlies pharmacoresistant seizuresR21NS080064 · NINDS · TUFTS UNIVERSITY BOSTON · PI MOSS, STEPHEN J · 2013 to 2014
$452k
NIMH NIH HHS R01 MH097446NINDS NIH HHS P01 NS054900NINDS NIH HHS R01 NS047478NINDS NIH HHS R01 NS048045NINDS NIH HHS R01 NS051195NINDS NIH HHS R01 NS056359NINDS NIH HHS R21 NS080064
6 · The paper itself

Abstract

The K-Cl cotransporter KCC2 establishes the low intraneuronal Cl- levels required for the hyperpolarizing inhibitory postsynaptic potentials mediated by ionotropic γ-aminobutyric acid receptors (GABAARs) and glycine receptors (GlyRs). Decreased KCC2-mediated Cl- extrusion and impaired hyperpolarizing GABAAR- and/or GlyR-mediated currents have been implicated in epilepsy, neuropathic pain, and spasticity. Recent evidence suggests that the intrinsic ion transport rate, cell surface stability, and plasmalemmal trafficking of KCC2 are rapidly and reversibly modulated by the (de)phosphorylation of critical serine, threonine, and tyrosine residues in the C terminus of this protein. Alterations in KCC2 phosphorylation have been associated with impaired KCC2 function in several neurological diseases. Targeting KCC2 phosphorylation directly or indirectly via upstream regulatory kinases might be a novel strategy to modulate GABA- and/or glycinergic signaling for therapeutic benefit.

Indexed as

AnimalsHumansK Cl- CotransportersModels, BiologicalNervous System DiseasesNeuronsPhosphorylationReceptors, GABAReceptors, GlycineSignal TransductionSymportersK Cl- CotransportersReceptors, GABAReceptors, GlycineSymporters

Identifiers

PMID24139641
PMCPMC4381966
OpenAlexW2043827139

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.